A Novel Approach to Flurbiprofen Pulsatile Colonic Release: Formulation and Pharmacokinetics of Double-Compression-Coated Mini-Tablets
- 28 May 2015
- journal article
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 16 (6) , 1465-1473
Abstract
A significant plan is executed in the present study to study the effect of double-compression coating on flurbiprofen core mini-tablets to achieve the pulsatile colonic delivery to deliver the drug at a specific time as per the patho-physiological need of the disease that results in improved therapeutic efficacy. In this study, pulsatile double-compression-coated tablets were prepared based on time-controlled hydroxypropyl methylcellulose K100M inner compression coat and pH-sensitive Eudragit S100 outer compression coat. Then, the tablets were evaluated for both physical evaluation and drug-release studies, and to prove these results, in vivo pharmacokinetic studies in human volunteers were conducted. From the in vitro drug-release studies, F6 tablets were considered as the best formulation, which retarded the drug release in the stomach and small intestine (3.42 ± 0.12% in 5 h) and progressively released to the colon (99.78 ± 0.74% in 24 h). The release process followed zero-order release kinetics, and from the stability studies, similarity factor between dissolution data before and after storage was found to be 88.86. From the pharmacokinetic evaluation, core mini-tablets producing peak plasma concentration (C max) was 14,677.51 ± 12.16 ng/ml at 3 h T max and pulsatile colonic tablets showed C max = 12,374.67 ± 16.72 ng/ml at 12 h T max. The area under the curve for the mini and pulsatile tablets was 41,238.52 and 72,369.24 ng-h/ml, and the mean resident time was 3.43 and 10.61 h, respectively. In conclusion, development of double-compression-coated tablets is a promising way to achieve the pulsatile colonic release of flurbiprofen.Keywords
This publication has 21 references indexed in Scilit:
- Colon Targeted Guar Gum Compression Coated Tablets of Flurbiprofen: Formulation, Development, and PharmacokineticsBioMed Research International, 2013
- Development, evaluation and pharmacokinetics of time-dependent ketorolac tromethamine tabletsExpert Opinion on Drug Delivery, 2012
- Colonic luminal surface retention of meloxicam microsponges delivered by erosion based colon-targeted matrix tabletInternational Journal of Pharmaceutics, 2012
- Microporous bilayer osmotic tablet for colon-specific deliveryEuropean Journal of Pharmaceutics and Biopharmaceutics, 2011
- Colon Specific Delivery of Indomethacin: Effect of Incorporating pH Sensitive Polymers in Xanthan Gum Matrix BasesAAPS PharmSciTech, 2009
- Development and in-vitro evaluation of a colon-specific controlled release drug delivery systemJournal of Pharmacy and Pharmacology, 2008
- Development and in-vitro evaluation of a colon-specific controlled release drug delivery systemJournal of Pharmacy and Pharmacology, 2008
- Optimizing delivery of flurbiprofen to the colon using a targeted prodrug approachJournal of Pharmacy and Pharmacology, 2008
- Biphasic release of indomethacin from HPMC/pectin/calcium matrix tablet: I. Characterization and mechanistic studyEuropean Journal of Pharmaceutics and Biopharmaceutics, 2007
- Characterization of 5-Fluorouracil Release from Hydroxypropylmethylcellulose Compression-Coated TabletsPharmaceutical Development and Technology, 2007